Terms: = Brain cancer AND CDKN1B, CDKN4, 1027, ENSG00000111276, MEN4, P27KIP1, P46527, MEN1B, KIP1
215 results:
1. Comparison of Optical Genome Mapping With Conventional Diagnostic Methods for Structural Variant Detection in Hematologic Malignancies.
Shim Y; Koo YK; Shin S; Lee ST; Lee KA; Choi JR
Ann Lab Med; 2024 Jul; 44(4):324-334. PubMed ID: 38433573
[TBL] [Abstract] [Full Text] [Related]
2. Malignant peripheral nerve sheath tumor (MPNST) and MPNST-like entities are defined by a specific DNA methylation profile in pediatric and juvenile population.
Patrizi S; Miele E; Falcone L; Vallese S; Rossi S; Barresi S; Giovannoni I; Pedace L; Nardini C; Masier I; Abballe L; Cacchione A; Russo I; Di Giannatale A; Di Ruscio V; Salgado CM; Mastronuzzi A; Ciolfi A; Tartaglia M; Milano GM; Locatelli F; Alaggio R
Clin Epigenetics; 2024 Jan; 16(1):9. PubMed ID: 38178234
[TBL] [Abstract] [Full Text] [Related]
3. Genetic testing in prolactinomas: a cohort study.
Boukerrouni A; Cuny T; Anjou T; Raingeard I; Ferrière A; Grunenwald S; Maïza JC; Marquant E; Sahakian N; Fodil-Cherif S; Salle L; Niccoli P; Randrianaivo H; Sonnet E; Chevalier N; Thuillier P; Vezzosi D; Reynaud R; Dufour H; Brue T; Tabarin A; Delemer B; Kerlan V; Castinetti F; Barlier A; Romanet P
Eur J Endocrinol; 2023 Dec; 189(6):567-574. PubMed ID: 37956455
[TBL] [Abstract] [Full Text] [Related]
4. Early Postnatal Expression of Tgfβ-1 and Fgf-2 Correlates With Regenerative Functions of Unrestricted Somatic Stem Cell Infusion After Rabbit GMH-IVH.
Finkel DA; Malfa A; Liao Y; Purohit D; Hu F; Sulaymankhil D; Abhishek Narra S; Hussein K; Subbian S; Cairo MS; Vinukonda G; La Gamma EF
Stem Cells Transl Med; 2023 Dec; 12(12):811-824. PubMed ID: 37774396
[TBL] [Abstract] [Full Text] [Related]
5. Clinical Factors Predicting Multiple Endocrine Neoplasia Type 1 and Type 4 in Patients with Neuroendocrine Tumors.
Faggiano A; Fazzalari B; Mikovic N; Russo F; Zamponi V; Mazzilli R; Guarnieri V; Piane M; Visco V; Petrucci S
Genes (Basel); 2023 Sep; 14(9):. PubMed ID: 37761922
[TBL] [Abstract] [Full Text] [Related]
6. DNA Methylation Pattern in Somatotroph Pituitary Neuroendocrine Tumors.
Kober P; Rymuza J; Baluszek S; Maksymowicz M; Nyc A; Mossakowska BJ; Zieliński G; Kunicki J; Bujko M
Neuroendocrinology; 2024; 114(1):51-63. PubMed ID: 37699356
[TBL] [Abstract] [Full Text] [Related]
7. A genomic score to predict local control among patients with brain metastases managed with radiation.
Lamba N; Cagney DN; Catalano PJ; Kim D; Elhalawani H; Haas-Kogan DA; Wen PY; Wagle N; Aizer AA
Neuro Oncol; 2023 Oct; 25(10):1815-1827. PubMed ID: 37260393
[TBL] [Abstract] [Full Text] [Related]
8. Pituitary Tumorigenesis-Implications for Management.
Vamvoukaki R; Chrysoulaki M; Betsi G; Xekouki P
Medicina (Kaunas); 2023 Apr; 59(4):. PubMed ID: 37109772
[TBL] [Abstract] [Full Text] [Related]
9. Pituitary tumours: molecular and genetic aspects.
De Sousa SMC; Lenders NF; Lamb LS; Inder WJ; McCormack A
J Endocrinol; 2023 Jun; 257(3):. PubMed ID: 36951812
[TBL] [Abstract] [Full Text] [Related]
10. Applying machine learning classifiers to automate quality assessment of paediatric dynamic susceptibility contrast (DSC-) MRI data.
Powell SJ; Withey SB; Sun Y; Grist JT; Novak J; MacPherson L; Abernethy L; Pizer B; Grundy R; Morgan PS; Jaspan T; Bailey S; Mitra D; Auer DP; Avula S; Arvanitis TN; Peet A
Br J Radiol; 2023 Apr; 96(1145):20201465. PubMed ID: 36802769
[TBL] [Abstract] [Full Text] [Related]
11. PRMT6-CDC20 facilitates glioblastoma progression via the degradation of cdkn1b.
Wang J; Xiao Z; Li P; Wu C; Li Y; Wang Q; Chen Y; Zhou H; Li Z; Wang Z; Lan Q; Wang Y
Oncogene; 2023 Mar; 42(14):1088-1100. PubMed ID: 36792756
[TBL] [Abstract] [Full Text] [Related]
12. MUC1 promotes glioblastoma progression and TMZ resistance by stabilizing EGFRvIII.
Tong F; Zhao JX; Fang ZY; Cui XT; Su DY; Liu X; Zhou JH; Wang GX; Qiu ZJ; Liu SZ; Fu JQ; Kang CS; Wang JC; Wang QX
Pharmacol Res; 2023 Jan; 187():106606. PubMed ID: 36516884
[TBL] [Abstract] [Full Text] [Related]
13. Germline cdkn1b variant type and site are associated with phenotype in men4.
Halperin R; Arnon L; Nasirov S; Friedensohn L; Gershinsky M; Telerman A; Friedman E; Bernstein-Molho R; Tirosh A
Endocr Relat Cancer; 2023 Jan; 30(1):. PubMed ID: 36256846
[TBL] [Abstract] [Full Text] [Related]
14. Paraneoplastic neurological syndromes associated with renal or bladder cancer: case series and PRISMA-IPD systematic review.
Villagrán-García M; Muñiz-Castrillo S; Ciano-Petersen NL; Vogrig A; Farina A; Villard M; Psimaras D; Alentorn A; Gonçalves D; Fabien N; Rogemond V; Joubert B; Honnorat J
J Neurol; 2023 Jan; 270(1):283-299. PubMed ID: 36050418
[TBL] [Abstract] [Full Text] [Related]
15. MicroRNA-575 acts as a novel oncogene via targeting multiple signaling pathways in glioblastoma.
Gray A; Cui T; Bell EH; McElroy J; Sebastian E; Li F; Geurts M; Liu K; Robe P; Haque SJ; Chakravarti A
Exp Mol Pathol; 2022 Oct; 128():104813. PubMed ID: 35901926
[TBL] [Abstract] [Full Text] [Related]
16. Dicer deficiency impairs proliferation but potentiates anti-tumoral effect of macrophages in glioblastoma.
Liu YQ; Luo M; Shi Y; Guo Y; Zhang H; Yang KD; Li TR; Yang LQ; Liu TT; Huang B; Liu Q; He ZC; Zhang XN; Wang WY; Wang S; Zeng H; Niu Q; Zhang X; Cui YH; Zhang ZR; Bian XW; Ping YF
Oncogene; 2022 Jul; 41(30):3791-3803. PubMed ID: 35764885
[TBL] [Abstract] [Full Text] [Related]
17. Immunohistochemical determination of mismatch repair gene product in colorectal carcinomas in a young indigenous African cohort.
Holla R; Vorster A; Locketz M; De Haas M; Oke OA; Govender D; Ramesar R; Goldberg PA
S Afr J Surg; 2022 Mar; 60(1):28-33. PubMed ID: 35451266
[TBL] [Abstract] [Full Text] [Related]
18. Case Report: New cdkn1b Mutation in Multiple Endocrine Neoplasia Type 4 and Brief Literature Review on Clinical Management.
Lavezzi E; Brunetti A; Smiroldo V; Nappo G; Pedicini V; Vitali E; Trivellin G; Mazziotti G; Lania A
Front Endocrinol (Lausanne); 2022; 13():773143. PubMed ID: 35355569
[TBL] [Abstract] [Full Text] [Related]
19. Loss of deubiquitylase USP2 triggers development of glioblastoma via TGF-β signaling.
Tu Y; Xu L; Xu J; Bao Z; Tian W; Ye Y; Sun G; Miao Z; Chao H; You Y; Liu N; Ji J
Oncogene; 2022 Apr; 41(18):2597-2608. PubMed ID: 35332268
[TBL] [Abstract] [Full Text] [Related]
20. men4, the MEN1 Mimicker: A Case Series of three Phenotypically Heterogenous Patients With Unique cdkn1b Mutations.
Seabrook A; Wijewardene A; De Sousa S; Wong T; Sheriff N; Gill AJ; Iyer R; Field M; Luxford C; Clifton-Bligh R; McCormack A; Tucker K
J Clin Endocrinol Metab; 2022 Jul; 107(8):2339-2349. PubMed ID: 35323929
[TBL] [Abstract] [Full Text] [Related]
[Next]
